Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Inactive

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

According to CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED latest financial report submitted on 2022-12-31, the company has a Cash of £5M, Total-Assets of £8M while the Working-Capital is £5M. Compared with the previous year, the company reported a Cash increase of 52.0%, which is an equivalent of -2619217. At the same time, the Total-Assets went up by 54.95%, or by -4374766.


Year:
2021 Not available
2020 Not available
2019 Not available
2018 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Profit after Tax

    £ -9.3 million

  • Working Capital

    £ 4.7 million

Working Capital

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Business Credit Report

A Business Credit Report for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Directors and key executives

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED currently employs 1 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees.
In order to view contact information, including emails and phone numbers for all the employees working at CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

1

100%

1y growth

100%

2y growth

Management Level


100

Middle

Employee Job Title Email Phone Country
Marella Thorell Director
-
- GB
David Chao Director
-
- GB
Richard Menziuso Director
-
- GB
Iqbal Hussain Director
-
- GB
Saurabh Saha Director
-
- GB

Get direct emails & phone numbers for senior executives working at «CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 1 people with significant control at CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED. One of of major shareholders of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED is CENTESSA PHARMACEUTICALS (UK) LIMITED, which owns 3546923 ORDINARY shares, with a total value of 0 GBP.


Name Quantity Share Type Value
CENTESSA PHARMACEUTICALS (UK) LIMITED
3546923 ORDINARY 0 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED news & activities:


EBITDA

The CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED-based company said the adjusted EBITDA is now -£11M, compared with the previous year of -16948557.

uk.globaldatabase.com

2022-12-31

Employees

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED number of employees has decreased by 0% compared with previous year and now represents a total number of 1.

uk.globaldatabase.com

2022-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED


Where is CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED registered office?

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED is located at 3rd Floor 1 Ashley Road, United Kingdom.

What is the website of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED?

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED website is http://morphogen-ix.com/

How many people work at CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED?

According to the latest account statement, there are currently 1 of employees working for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED.

What is CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED EBITDA?

For 2022, CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED has reported an EBITDA of -£11M, which went up by 52.68% compared to previous year.

What is the Business Credit Score of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED and how reliable is the company?

In order to check the business credit score of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED pay their invoices on time?

By requesting a Business Credit Report for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED, you will be able to gain more insights about the CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED payment trends.

Who is the Ultimate Parent of the CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED?

Information about the ultimate beneficial ownership CENTESSA PHARMA************* of CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action